Vascular dementia and Paranasal sinus hypersecretion

Summary:

Paranasal sinus hypersecretion is reported only by a few people with Vascular dementia.

The study analyzes which people have Paranasal sinus hypersecretion with Vascular dementia. It is created by eHealthMe based on 1 person who has Paranasal sinus hypersecretion and Vascular dementia from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 07, 2022

1 person who has Vascular Dementia and Paranasal Sinus Hypersecretion is studied.


What is Vascular dementia?

Vascular dementia (vascular dementia is a general term describing problems with reasoning, planning, judgment, memory and other thought) is found to be associated with 2,301 drugs and 1,700 conditions by eHealthMe.

What is Paranasal sinus hypersecretion?

Paranasal sinus hypersecretion is found to be associated with 729 drugs and 395 conditions by eHealthMe.

Number of Paranasal sinus hypersecretion in Vascular dementia reports submitted per year:

Would you have Paranasal sinus hypersecretion when you have Vascular dementia?

Gender of people who have Vascular Dementia and experienced Paranasal Sinus Hypersecretion *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Vascular Dementia and experienced Paranasal Sinus Hypersecretion *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common co-existing conditions for these people *:

  1. Stress And Anxiety: 1 person, 100.00%
  2. Pulmonary Mycosis (lung infection caused by yeast-like fungi): 1 person, 100.00%
  3. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 1 person, 100.00%
  4. Memory Loss: 1 person, 100.00%
  5. Laxative Supportive Care: 1 person, 100.00%
  6. Appetite Disorder (abnormal eating habits): 1 person, 100.00%
  7. Abdominal Discomfort: 1 person, 100.00%

Common drugs taken by these people *:

  1. Vfend: 1 person, 100.00%
  2. Pepcid: 1 person, 100.00%
  3. Claritin: 1 person, 100.00%
  4. Aricept: 1 person, 100.00%

Common symptoms for these people *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 100.00%
  2. Cardiac Failure Congestive: 1 person, 100.00%
  3. Abdominal Discomfort: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Paranasal sinus hypersecretion?

Check whether Paranasal sinus hypersecretion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Paranasal sinus hypersecretion:

Common drugs associated with Paranasal sinus hypersecretion:

All the drugs that are associated with Paranasal sinus hypersecretion:

Common conditions associated with Paranasal sinus hypersecretion:

All the conditions that are associated with Paranasal sinus hypersecretion:

How the study uses the data?

The study is based on Paranasal sinus hypersecretion and Vascular dementia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: